Department of the Army 2010 – Federal Register Recent Federal Regulation Documents

Announcement is made of the availability for licensing of the invention set forth in U.S. Patent 6,254,873 which issued July 3, 2001, entitled ``Inactivated Dengue Virus Vaccine,'' and U.S. Patent 6,190,859, entitled ``Method and Kit for Detection of Dengue Virus,'' issued February 20, 2001. The United States Government, as represented by the Secretary of the Army, has rights to this invention.

The Department of the Army intends to prepare a PEIS to analyze the environmental and socioeconomic impacts associated with the proposed land acquisition and use of approximately 22,232 acres for implementation of an RPMP and mission activities in south Texas. The proposed land area, currently in private ownership, would become the STTC. This action will support the training requirements of the TXARNG units located in central and south Texas. The PEIS will analyze alternatives that are deemed feasible to meet the purpose and need for this Proposed Action.

Section 302 of Public Law 99-662 established the Inland Waterways Users Board. The Board is an independent Federal advisory committee. The Secretary of the Army appoints its 11 members. This notice is to solicit nominations for 10 (ten) appointments or reappointments to two-year terms that will begin after June 15, 2011.

Department of the Army is to alter a system of records notices in its existing inventory of record systems subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended.

Announcement is made of the availability for licensing of the invention set forth in patent application PCT/US2009/060850, entitled ``Clinical Decision Model,'' filed October 15, 2009. The United States Government, as represented by the Secretary of the Army, has rights to this invention.

The Department of the Army proposes to add a system of records to its inventory of record systems subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended.

In accordance with 35 U.S.C. 209(e), and 37 CFR 404.7 (a)(1)(i) and 37 CFR 404.7 (b)(1)(i), announcement is made of the intent to grant an exclusive, revocable license for the invention claimed in the patent application PCT/US2009/045818, filed June 1, 2009, entitled, ``Meningococcal Multivalent Native Outer Membrane Vesicle Vaccine, Methods of Making and Use Thereof,'' to Merck Sharp & Dohme Corp., with its principal place of business at One Merck Drive, Whitehouse Station, NJ 08889-3400.

The Department of the Army is deleting a systems of record notice from its existing inventory of record systems subject to the Privacy Act of 1974, (5 U.S.C. 552a), as amended.

In accordance with 35 U.S.C. 209(e), and 37 CFR 404.7 (a)(1)(i) and 37 CFR 404.7 (b)(1)(i), announcement is made of the intent to grant an exclusive, revocable license for the invention claimed in U.S. Patent Application No. 12/670,250, entitled ``Obstetrics Simulation and Training Method and System,'' filed on January 22, 2010, and related foreign patent applications deriving from PCT/US2008/076725 to Gaumard Scientific Company, Inc., with its principal place of business at 14700 SW 136 Street, Miami, FL 33196- 5691.

The Department of the Army announces the availability of the Draft PEIS for the proposed growth, realignment, and stationing of new and existing Army aviation assets. The proposed action includes the consolidation and reorganization of existing aviation units, and the potential establishment of one or more Combat Aviation Brigades (CABs). The proposed action will increase the availability of helicopter assets to meet current and future national security requirements and will allow the Army better to organize existing aviation assets to promote more effective training and force management. The Draft PEIS evaluates the environmental impacts associated with the proposed action, which also includes the construction and renovation of garrison facilities, as well as additional training needed to support the aviation units. Land acquisition is not being considered as part of this action. The Draft PEIS considers the following alternatives: Alternative 1Realign and Station Existing Aviation Elements of Up to a Full CAB or Activate and Station a New CAB at Fort Carson, Colorado. Under this alternative, the Army either will consolidate existing aviation units not currently assigned to a CAB into a standard CAB structure at Fort Carson or activate a new CAB at Fort Carson. As part of this alternative, aviation units will conduct training on existing land at Pinon Canyon Maneuver Site (PCMS), Colorado, in order to maintain training proficiency and support integrated training with ground units. Land acquisition is not being considered as part of this action. Alternative 2Realign and Station Existing Aviation elements of Up to a Full CAB or Grow, Station and Activate a CAB at Joint Base Lewis- McChord (JBLM) Washington. Under this alternative, the Army either will consolidate existing aviation units not currently assigned to a CAB into a standard CAB structure at JBLM or activate a new CAB at JBLM. As part of this alternative, aviation units will conduct training on existing training land at Yakima Training Center (YTC), Washington, in order to maintain training proficiency and support integrated training with ground units. Land acquisition is not being considered as part of this action. Alternative 3Implement Alternatives 1 and 2 (preferred alternative). Under this alternative, the Army will implement both alternatives. Under this alternative, the consolidated units forming a CAB would be stationed at one installation, and the new CAB would be activated and stationed at the other installation. Fort Carson and JBLM would each gain up to one CAB. As part of this alternative, aviation units would conduct training on existing training land at the installation's training maneuver area (PCMS for Fort Carson and YTC for JBLM) in order to maintain training proficiency and support integrated training with ground units. Alternative 4No Action Alternative. Under this alternative, the Army would retain its aviation force structure at its current levels, configurations, and locations. Fort Carson and JBLM are the only stationing alternatives that meet all of the Army's stationing requirements for new CAB stationing. These locations have existing runways and airfields, provide adequate maneuver and airspace for CAB operations, and are equipped with existing training ranges that can support CAB training. Most importantly, Fort Carson and JBLM are the only major installations that have three or more Brigade Combat Teams but no CAB dedicated to provide aviation support for training. The proposed action would allow the Army to maximize integrated air-ground training. Land acquisition is not being considered as part of this action.

Department of the Army is altering a system of records notices in its existing inventory of record systems subject to the Privacy Act of 1974, (5 U.S.C. 552a), as amended.

Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 12/670,250, entitled ``Obstetrics Simulation and Training Method and System,'' filed January 22, 2010. Foreign rights are also available for licensing (PCT/US2008/076725). The United States Government, as represented by the Secretary of the Army, has rights to this invention.

Under the provisions of the Federal Advisory Committee Act of 1972, the Government in the Sunshine Act of 1976, and Federal regulations governing advisory committee meetings, the Department of Defense announces a Federal advisory committee meeting for the United States Military Academy Board of Visitors. This is the 2010 Annual Meeting of the USMA Board of Visitors. Members of the Board will be provided updates on Academy issues.

The Department of the Army proposes to add a system of records to its inventory of record systems subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended.

The Military Surface Deployment and Distribution Command (SDDC) is providing notice that it is releasing an interim change to the MFTURP No. 1 on October 1, 2010. The interim change updates Section B, Item 21, Detention: Vehicles With Power Units (DEP).

In accordance with 35 U.S.C. 209(e), and 37 CFR 404.7 (a)(1)(i) and 404.7(b)(1)(i), announcement is made of the intent to grant a field of use exclusive, revocable license for the field of prevention and/or therapeutic treatment of vaccinia virus infections or other orthopoxvirus infections to the inventions claimed in U.S. Patent No. 6,451,309 entitled ``Prophylactic and Therapeutic Monoclonal Antibodies,'' issued September 17, 2002, and U.S. Patent No. 6,620,412 entitled ``Prophylactic and Therapeutic Monoclonal Antibodies,'' issued September 16, 2003, which is a continuation of U.S. Patent No. 6,451,309, and related foreign patents and patent applications (PCT/ US2001/04520) to Biofactura, Inc., with its principal place of business at 9430 Key West Avenue, Suite 125, Rockville, MD 20850-6345.

The Department of the Army announces the availability of an FEIS for Fort Lewis and YTC that analyzes the environmental impacts of implementing the decisions in the 2007 Army Growth and Force Structure Realignment Programmatic EIS (also referred to as the Grow The Army PEIS or GTA PEIS) and other ongoing Army realignment and stationing initiatives, such as the potential for Combat Aviation Brigade (CAB) stationing that may potentially effect Fort Lewis and YTC. The Proposed Action could station up to 5,700 Soldiers and their Families at Fort Lewis. The Proposed Action includes the stationing of 1,900 Soldiers directed under the GTA PEIS, the potential additional stationing of up to 1,000 combat service support (CSS) Soldiers, and the potential stationing of a medium Combat Aviation Brigade (CAB) of approximately 2,800 Soldiers for a total of up to 5,700 Soldiers. After reviewing the alternatives analyzed in the FEIS, the Army has identified Alternative 4 as its preferred alternative, which includes all components of the GTA, CSS, and CAB alternatives (up to a total of 5,700 Soldiers and 8,260 family members).

In accordance with 35 U.S.C. 209(e), and 37 CFR 404.7 (a)(1)(i), announcement is made of the intent to grant an exclusive, revocable license for the field of use in the research reagent market to the invention described in U.S. Patent Application No. 61/252,675 entitled ``Enhanced Substrates for The Protease Activity of Serotype A Botulinum Neurotoxin,'' filed October 18, 2009, to List Biological Laboratories, with its principal place of business at 540 Division Street, Campbell, California 95008-6906.

The Department of the Army announces the availability of a ROD that documents and summarizes the implementation of the preferred alternative described in the Fort Bliss Army Growth and Force Structure Realignment Final Environmental Impact Statement (hereinafter referred to as the FEIS). The preferred alternative consists of actions in three different categories (stationing/training, land use changes, and training infrastructure improvements) of interrelated alternatives.

The Department of the Army is proposing to amend a system of records notice in its existing inventory of records systems subject to the Privacy Act of 1974, (5 U.S.C. 552a), as amended.

Under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended) and 41 CFR 102-3.150, the Department of Defense announces that the following Federal advisory committee meeting will take place:

Under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended) and 41 CFR 102-3.150, the Department of Defense announces that the following Federal advisory committee meeting will take place:

Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 12/149,076, entitled ``Combinations of Gene Deletions for Live Attenuated Shigella Vaccine Strains,'' filed April 25, 2008. Foreign rights are also available for licensing (PCT/US2008/005342). The United States Government, as represented by the Secretary of the Army, has rights to this invention.

Announcement is made of the availability for licensing of the invention set forth in U.S. Patent 7,632,659, which issued on December 15, 2009, entitled ``Use of Shigella Invaplex to Transport Functional Proteins and Transcriptionally Active Nucleic Acids Across Mammalian Cell Membranes In Vitro and In Vivo,'' and U.S. Patent Application Serial No. 12/563,794, entitled ``Use of Shigella Invaplex to Transport Functional Proteins and Transcriptionally Active Nucleic Acids Across Mammalian Cell Membranes In Vitro and In Vivo,'' filed September 21, 2009. U.S. Patent Application Serial No. 12/563,794 is a continuation application of U.S. Patent 7,632,659. Foreign rights are also available for licensing (PCT/US2004/039100). The United States Government, as represented by the Secretary of the Army, has rights to this invention.